Ravi Kant Sarogi

Statistics

Publications

Citations

H-Index

Active since

2018

Affiliations

Ravi Kant Sarogi is an author at Columbia Asia specializing in hydroxychloroquine therapy, hydroxychloroquine treatment, and type 2 diabetes treatment.

Publications per year

2018–2018

Publications

Efficacy and safety of substituting teneligliptin with hydroxychloroquine in inadequately controlled type 2 diabetes subjects with combination therapy of teneligliptin, metformin and glimepiride with or without other antidiabetic therapy: The TENE-HYQ SHIFT Study

U. Singh, Arjun Baidya, Manikant Singla et al. · Clinical Diabetology · 2018 · 10 citations · Full text

Medicine, Endocrinology, Pharmacotherapy +17

1–1 of 1